Synthesis and CHK1 inhibitory potency of Hymenialdisine analogues

被引：31
|
作者：
Parmentier, Jean-Gilles [1 ]
Portevin, Bernard [1 ]
Golsteyn, Roy M. [2 ]
Pierre, Alain [2 ]
Hickman, John [2 ]
Gloanec, Philippe [1 ]
De Nanteuil, Guillaume [1 ]
机构：
[1] Inst Rech Servier, Med Chem Div D, F-92150 Suresnes, France
[2] Inst Rech Servier, Div Cancerol, F-78290 Croissy Sur Seine, France
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 03期
关键词：
Hymenialdisine; CHK1; inhibitor; CHECKPOINT; KINASES;
D O I：
10.1016/j.bmcl.2008.12.001
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of thieno[3,2-b]pyrroloazepinones derivatives related to Hymenialdisine were prepared and tested for CHK1 inhibitory activity. Nanomolar inhibitions were achieved when electron-withdrawing substituents were introduced at position 3 of the thiophene ring. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码：841 / 844
页数：4
相关论文
共 50 条
  • [21] Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinase
    Garbaccio, Robert M.
    Huang, Shaei
    Tasber, Edward S.
    Fraley, Mark E.
    Yan, Youwei
    Munshi, Sanjeev
    Ikuta, Mari
    Kuo, Lawrence
    Kreatsoulas, Constanine
    Stirdivant, Steve
    Drakas, Bob
    Rickert, Keith
    Walsh, Eileen S.
    Hamilton, Kelly A.
    Buser, Carolyn A.
    Hardwick, James
    Mao, Xianzhi
    Beck, Stephen C.
    Abrams, Marc T.
    Tao, Weikang
    Lobell, Rob
    Sepp-Lorenzino, Laura
    Hartman, George D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) : 6280 - 6285
  • [22] Unleashing Chk1 in cancer therapy
    Carrassa, Laura
    Damia, Giovanna
    CELL CYCLE, 2011, 10 (13) : 2121 - 2128
  • [23] Exploring the effects of PARP inhibition on CHK1 activation as a potential determinant of synergy with CHK1 inhibition.
    Wielgos-Bonvallet, Monicka
    Cybulska, Paulina
    Van Oudenhove, Elke
    Jelinic, Petar
    Levine, Douglas A.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 28 - +
  • [24] Lighting ATR/Chk1 by condensates
    Qin, Yan
    Shi, Lei
    TRENDS IN CELL BIOLOGY, 2024, 34 (06) : 440 - 441
  • [25] Chk1 suppressed cell death
    Mark Meuth
    Cell Division, 5
  • [26] The 1.7 Å crystal structure of human cell cycle checkpoint kinase Chk1:: Implications for Chk1 regulation
    Chen, P
    Luo, C
    Deng, YL
    Ryan, K
    Register, J
    Margosiak, S
    Tempczyk-Russell, A
    Nguyen, B
    Myers, P
    Lundgren, K
    Kan, CC
    O'Connor, PM
    CELL, 2000, 100 (06) : 681 - 692
  • [27] Dominant mutations in CHK1 cause pronuclear fusion failure and zygote arrest that can be rescued by CHK1 inhibitor
    Honghui Zhang
    Tailai Chen
    Keliang Wu
    Zhenzhen Hou
    Shigang Zhao
    Chuanxin Zhang
    Yuan Gao
    Ming Gao
    Zi-Jiang Chen
    Han Zhao
    Cell Research, 2021, 31 : 814 - 817
  • [28] Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy
    Massey, Andrew J.
    CANCER LETTERS, 2016, 383 (01) : 41 - 52
  • [29] Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation
    Yu, Xinfang
    Li, Wei
    Liu, Haidan
    Deng, Qipan
    Wang, Xu
    Hu, Hui
    Xu-Monette, Zijun Y.
    Xiong, Wei
    Lu, Zhongxin
    Young, Ken H.
    Wang, Wei
    Li, Yong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [30] Alterations of Chk1 and Chk2 expression in colon cancer
    Stawinska, Magdalena
    Cygankiewicz, Adam
    Trzcinski, Radzislaw
    Mik, Michal
    Dziki, Adam
    Krajewska, Wanda M.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (12) : 1243 - 1249
12345